PBH
Price
$79.98
Change
-$0.20 (-0.25%)
Updated
Jul 3 closing price
Capitalization
3.6B
26 days until earnings call
VTRS
Price
$9.32
Change
-$0.02 (-0.21%)
Updated
Jul 3 closing price
Capitalization
14.18B
33 days until earnings call
Interact to see
Advertisement

PBH vs VTRS

Header iconPBH vs VTRS Comparison
Open Charts PBH vs VTRSBanner chart's image
Prestige Consumer Healthcare
Price$79.98
Change-$0.20 (-0.25%)
Volume$243.05K
Capitalization3.6B
Viatris
Price$9.32
Change-$0.02 (-0.21%)
Volume$6.34M
Capitalization14.18B
PBH vs VTRS Comparison Chart in %
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. VTRS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Hold and VTRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (PBH: $79.98 vs. VTRS: $9.32)
Brand notoriety: PBH and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PBH: 65% vs. VTRS: 43%
Market capitalization -- PBH: $3.6B vs. VTRS: $14.18B
PBH [@Pharmaceuticals: Other] is valued at $3.6B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, PBH is a better buy in the long-term than VTRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • PBH’s TA Score: 4 bullish, 5 bearish.
  • VTRS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both PBH and VTRS are a good buy in the short-term.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а -1.44% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

PBH is expected to report earnings on Jul 31, 2025.

VTRS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than PBH($3.6B). VTRS has higher P/E ratio than PBH: VTRS (238.80) vs PBH (14.90). PBH YTD gains are higher at: 2.420 vs. VTRS (-23.112). VTRS has higher annual earnings (EBITDA): 3.52B vs. PBH (10.8M). VTRS has more cash in the bank: 1.18B vs. PBH (63.6M). PBH has less debt than VTRS: PBH (1.21B) vs VTRS (18.4B). VTRS has higher revenues than PBH: VTRS (15.4B) vs PBH (1.13B).
PBHVTRSPBH / VTRS
Capitalization3.6B14.2B25%
EBITDA10.8M3.52B0%
Gain YTD2.420-23.112-10%
P/E Ratio14.90238.806%
Revenue1.13B15.4B7%
Total Cash63.6M1.18B5%
Total Debt1.21B18.4B7%
FUNDAMENTALS RATINGS
PBH vs VTRS: Fundamental Ratings
PBH
VTRS
OUTLOOK RATING
1..100
5383
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
6094
PRICE GROWTH RATING
1..100
5953
P/E GROWTH RATING
1..100
381
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (14) in the null industry is significantly better than the same rating for PBH (85) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew significantly faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for VTRS (100) in the null industry. This means that PBH’s stock grew significantly faster than VTRS’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for VTRS (94) in the null industry. This means that PBH’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (53) in the null industry is in the same range as PBH (59) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to PBH’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for PBH (38) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHVTRS
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
44%
Bullish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 26 days ago
59%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 6 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
39%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SIL49.090.38
+0.78%
Global X Silver Miners ETF
CMDT25.930.05
+0.19%
PIMCO Commodity Strategy Act Exc-Trd Fd
ABNY11.740.01
+0.11%
YieldMax ABNB Option Income Strategy ETF
EMXF42.90N/A
N/A
iShares ESG Advanced MSCI EM ETF
DEFI123.99-0.22
-0.18%
Hashdex Bitcoin ETF

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.25%
PAHC - PBH
48%
Loosely correlated
+0.21%
VTRS - PBH
36%
Loosely correlated
-0.21%
AMRX - PBH
30%
Poorly correlated
+0.60%
ZTS - PBH
29%
Poorly correlated
+0.06%
PRGO - PBH
27%
Poorly correlated
-0.22%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.21%
ELAN - VTRS
46%
Loosely correlated
-0.54%
ZTS - VTRS
43%
Loosely correlated
+0.06%
AMRX - VTRS
43%
Loosely correlated
+0.60%
PAHC - VTRS
40%
Loosely correlated
+0.21%
PBH - VTRS
36%
Loosely correlated
-0.25%
More